Gunnar Wagenius

1.9k total citations
80 papers, 1.5k citations indexed

About

Gunnar Wagenius is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Gunnar Wagenius has authored 80 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 42 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Gunnar Wagenius's work include Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Diagnosis and Treatment (16 papers). Gunnar Wagenius is often cited by papers focused on Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Diagnosis and Treatment (16 papers). Gunnar Wagenius collaborates with scholars based in Sweden, United Kingdom and United States. Gunnar Wagenius's co-authors include Daniel Brattström, Patrik Hesselius, Michael Bergqvist, Ola Brodin, Mats Lambe, Stefan Bergström, Johan Hansson, Anders Larsson, Kristina Lamberg and Ulrika Stierner and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Gunnar Wagenius

77 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gunnar Wagenius Sweden 23 873 600 417 196 164 80 1.5k
Melissa Bersanelli Italy 19 821 0.9× 796 1.3× 479 1.1× 192 1.0× 295 1.8× 102 1.4k
Véronique D’Hondt France 21 781 0.9× 335 0.6× 298 0.7× 144 0.7× 241 1.5× 83 1.3k
Emily Dunn United States 13 873 1.0× 492 0.8× 741 1.8× 132 0.7× 220 1.3× 24 1.7k
Alessandra Ravaioli Italy 19 913 1.0× 533 0.9× 210 0.5× 161 0.8× 209 1.3× 107 1.3k
Amy Tiersten United States 20 1.0k 1.2× 324 0.5× 264 0.6× 143 0.7× 275 1.7× 101 1.6k
Eduard Vrdoljak Croatia 15 435 0.5× 617 1.0× 465 1.1× 167 0.9× 308 1.9× 78 1.2k
Julia Wilkerson United States 20 608 0.7× 713 1.2× 501 1.2× 188 1.0× 284 1.7× 44 1.8k
Yan Song United States 20 613 0.7× 435 0.7× 419 1.0× 251 1.3× 206 1.3× 132 1.5k
Aránzazu Manzano Spain 16 571 0.7× 308 0.5× 240 0.6× 216 1.1× 200 1.2× 58 1.1k
Lissandra Dal Lago Belgium 18 1.2k 1.3× 254 0.4× 305 0.7× 124 0.6× 219 1.3× 54 1.7k

Countries citing papers authored by Gunnar Wagenius

Since Specialization
Citations

This map shows the geographic impact of Gunnar Wagenius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Wagenius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Wagenius more than expected).

Fields of papers citing papers by Gunnar Wagenius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gunnar Wagenius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Wagenius. The network helps show where Gunnar Wagenius may publish in the future.

Co-authorship network of co-authors of Gunnar Wagenius

This figure shows the co-authorship network connecting the top 25 collaborators of Gunnar Wagenius. A scholar is included among the top collaborators of Gunnar Wagenius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunnar Wagenius. Gunnar Wagenius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wagenius, Gunnar, Anders Vikström, Anders Berglund, et al.. (2025). Long-term real-world outcomes of first-line immunotherapy in non-small cell lung cancer – a population-based cohort study in Sweden. Acta Oncologica. 64. 415–422. 2 indexed citations
3.
Wagenius, Gunnar, Anders Vikström, Anders Berglund, et al.. (2024). First-line Treatment Patterns and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden: A Population-based Real-world Study with Focus on Immunotherapy. Acta Oncologica. 63. 198–205. 3 indexed citations
4.
Berglund, Anders, Stefan Bergström, Johan Isaksson, et al.. (2022). Patterns of care and outcomes in immigrants with non-small cell lung cancer. A population-based study (Sweden). PLoS ONE. 17(12). e0278706–e0278706. 3 indexed citations
5.
Berglund, Anders, et al.. (2019). Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study. Lung Cancer. 131. 40–46. 21 indexed citations
6.
Lyth, Johan, Johan Hansson, Christian Ingvar, et al.. (2012). Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark’s level of invasion: results of a population-based study from the Swedish Melanoma Register. British Journal of Dermatology. 168(4). 779–786. 33 indexed citations
7.
Ullenhag, Gustav, et al.. (2012). Rapid expansion of T cells: Effects of culture and cryopreservation and importance of short-term cell recovery. Acta Oncologica. 52(5). 978–986. 10 indexed citations
8.
Berglund, Anders, Lars Holmberg, Carol Tishelman, et al.. (2010). Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden. Thorax. 65(4). 327–333. 61 indexed citations
9.
Nyman, Jan, Andreas Hallqvist, Ola Brodin, et al.. (2009). Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: a phase II study from the Swedish Lung Cancer Study Group. Journal of Thoracic Oncology. 4(9). 373–373. 1 indexed citations
10.
Nyman, Jan, Signe Friesland, Andreas Hallqvist, et al.. (2008). How to improve loco-regional control in stages IIIa–b NSCLC?. Lung Cancer. 65(1). 62–67. 23 indexed citations
11.
Wanders, Alkwin, Daniel Brattström, Stefan Bergström, et al.. (2006). HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival. Diseases of the Esophagus. 19(4). 224–231. 45 indexed citations
12.
Brattström, Daniel, Gunnar Wagenius, Per Sandström, et al.. (2005). Newly developed assay measuring cytokeratins 8, 18 and 19 in serum is correlated to survival and tumor volume in patients with esophageal carcinoma. Diseases of the Esophagus. 18(5). 298–303. 11 indexed citations
13.
Bergqvist, Michael, Daniel Brattström, David Brodin, et al.. (2005). Genes associated with telomerase activity levels in esophageal carcinoma cell lines. Diseases of the Esophagus. 19(1). 20–23. 6 indexed citations
14.
Wagenius, Gunnar, Stefan Bergström, Daniel Brattström, et al.. (2005). The Role of Cystatin C and the Angiogenic Cytokines VEGF and bFGF in Patients with Esophageal Carcinoma. Medical Oncology. 22(1). 29–38. 15 indexed citations
15.
Lindholm, Christer, Monika Dufmats, Johan Hansson, et al.. (2004). Invasive cutaneous malignant melanoma in Sweden, 1990–1999. Cancer. 101(9). 2067–2078. 83 indexed citations
16.
Hansson, Johan, Hans Ehrsson, Staffan Eksborg, et al.. (2004). High‐Dose Cisplatin With Amifostine: Ototoxicity and Pharmacokinetics. The Laryngoscope. 114(9). 1660–1667. 29 indexed citations
17.
Stockeld, Dag, Jan Tennvall, Gunnar Wagenius, et al.. (2001). A Swedish Study of Chemoradiation in Squamous Cell Carcinoma of the Esophagus. Acta Oncologica. 40(5). 566–573. 18 indexed citations
18.
Mýrdal, Gunnar, Mats Lambe, Reinhold Bergström, et al.. (2001). Trends in lung cancer incidence in Sweden with special reference to period and birth cohorts. Cancer Causes & Control. 12(6). 539–549. 14 indexed citations
19.
Brattström, Daniel, Mattias Bergqvist, Anders Larsson, et al.. (1997). Basic fibroblast growth factor and vascular fibroblast growth factor measured in sera from patients with non-small cell lung cancer.. Tumor Biology. 18. 3 indexed citations
20.
Manegold, C., Bengt Bergman, A. Chemaissani, et al.. (1997). Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer. Annals of Oncology. 8(6). 525–529. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa Bersanelli Breakdown of academic impact, for papers by Véronique D’Hondt Breakdown of academic impact, for papers by Emily Dunn Breakdown of academic impact, for papers by Alessandra Ravaioli Breakdown of academic impact, for papers by Amy Tiersten Breakdown of academic impact, for papers by Eduard Vrdoljak Breakdown of academic impact, for papers by Julia Wilkerson Breakdown of academic impact, for papers by Yan Song Breakdown of academic impact, for papers by Aránzazu Manzano Breakdown of academic impact, for papers by Lissandra Dal Lago
Rankless by CCL
2026